Andrea Charles

---For immediate release--- In the wake of high profile staff cuts at multinational global pharmaceutical and biotech companies, leading industry network Pharma IQ conducted a large scale study in...

Pharma IQ is pioneering new HTA discussion platform with launch of the first ever HTA Online event - Global HTA and CER Forum, which will take an innovative form of 12 online session over the course o...

Despite all the talk of cost cutting and increasing efficiency, the number one priority for key stakeholders in the clinical trial supply arena is supporting the expansion of new trials, into new ther...

Health Technology Assessment (HTA) is climbing up the agenda in many European countries due to increasing healthcare costs and budgetary pressures. Limited resource According to the European Society...

The US government's heavy investment in comparative effectiveness research (CER) will not transform the healthcare system, due to the large numbers of uninsured Americans who need to be abs...

The prefilled syringes sector has witnessed healthy growth in recent years and demand is expected to rise. This is due to the increased number of injectable biological drugs in the...

Biological shift A growing biotechnology pipeline is fuelling the demand for lyophilisation technologies, and drug companies are looking to partner with contract manufacturing organisations (CMOs...

Pharmaceutical companies are looking at global sourcing to improve their profits. North America is currently leading the overall contract manufacturing market. However, according to a recent...

You only need to search on Google to find the endless list of global and local contract research service providers. The current Contract Research Organisation (CRO) landscape is vast, with offerings...

If you are going to fail, it is better to fail earlier. All phases of clinical research are striving to reduce attrition, streamline their processes and develop drugs cost-effectively.